Immunology biotech Agomab…
Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both [...]
Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both [...]
Robert G. Kramer sold nearly 90,000 shares of his stock [...]
Just days after AbbVie unveiled a major new oncology play [...]
With Fujifilm Biotechnologies now among the top echelon of CDMOs [...]
For the fourth year running—and the third in a row [...]
Vedanta Biosciences has “significantly reduced” its headcount to channel its [...]
Exelixis may only have one drug on the market right [...]
ImmunityBio has reported ongoing complete responses of up to 15 [...]
The long-awaited plan would leave much to Congress and calls [...]
The leaders of Chugai Pharmaceutical are tired of their company [...]